TG Therapeutics | TGTX - Umlaufvermögen

Aktienkurs
33.73
Täglich Wechseln
-0.90 -2.60%
Monatlich
20.25%
Jährlich
-8.12%
Q2 Prognose
32.81




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Ardelyx USD 382.32M 14.33M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Bayer EUR 32.91B 30M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Curis USD 6.92M 7.5M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novavax USD 978.28M 3.69M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Verastem USD 223.41M 69.36M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12